Please login to the form below

Not currently logged in
Email:
Password:

Semma Therapeutics

This page shows the latest Semma Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Vertex gains FDA fast track designation for diabetes stem cell therapy

Vertex gains FDA fast track designation for diabetes stem cell therapy

Vertex gained VX-880 from its previous acquisition of Semma Therapeutics for $950m in September 2019. ... This programme has its roots in the groundbreaking work that began in Dr Doug Melton’s lab, progressed at Semma Therapeutics, and has been

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure deal, at $790m. ... Antibody sequence for use with Trieza's viral vector technology. Semma Therapeutics.

  • Pharma deals in March 2015 Pharma deals in March 2015

    Fujifilm expects to achieve significant synergies. Checkpoint inhibitors are not being left behind with two deals this month, one by Blueprint Ventures and the other by Checkpoint Therapeutics but neither are ... This month Semma Therapeutics raised $44m

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....